PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy

Authors

Institutions

Publication Details

Journal
Journal of Hematology & Oncology
Published
2025-12-07
DOI
https://doi.org/10.1186/s13045-025-01768-1
Citations
1
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy

Mustafa Dikilitaş, Rui Mao, Lühua Wang, Hong Ge et al.
1 citations
Journal of Hematology & Oncology
Lung Cancer Treatments and Mutations
1.52
article

PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy

Mustafa Dikilitaş, Rui Mao, Lühua Wang, Hong Ge, Timuçin Çil, E Mingyan, Dongqing Lv, Yi Pan, Maciej Jerzy Krzakowski, Lin Wu, Nan Bi, Wei Zhang, Yi-Long Lung Cancer Wu, Jianguo Sun, B. Zhang, Young‐Chul Kim, Chih‐Liang Wang, Yanjiao Yang, Mehmet Ali Nahit Sendur, Zhengfei Zhu
article en
1 citations

Abstract

No abstract available for this paper.
Journal of Hematology & OncologyVol. 18(1)
Tongji University (CN), Central South University (CN), Ankara University (TR), Army Medical University (CN), Harbin Medical University (CN), Dalian Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Inonu University (TR), Wenzhou Medical University (CN), Chang Gung Memorial Hospital (TW), Zhengzhou University (CN), National Cancer Center (US), Fudan University Shanghai Cancer Center (CN), Second Affiliated Hospital of Chongqing Medical University (CN), Memorial Ankara Hospital (TR), Third Affiliated Hospital of Harbin Medical University (CN), Hunan Cancer Hospital (CN), Shanghai Pulmonary Hospital (CN), Başkent University Hospital (TR), AstraZeneca (Poland) (PL), Henan Cancer Hospital (CN), Guangdong Academy of Medical Sciences (CN), Chonnam National University Hwasun Hospital (KR), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Zhejiang Taizhou Hospital (CN), AstraZeneca (Germany) (DE), Turgut Özal University (TR), Chongqing Medical University (CN)
Openalex Percentile: Top 12%
Lung Cancer Treatments and Mutations
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.